Feeds
5250 items (5250 unread) in 74 feeds
Acinar Cell Carcinoma
(12 unread)
Acinic Cell Carcinoma
(18 unread)
Adenoid Cystic Carcinoma
(90 unread)
Adrenal Gland Cancer
(452 unread)
Ampulla Of Vater
(60 unread)
Anal Cancer
(494 unread)
Angiosarcoma
(130 unread)
Appendix Cancer
(85 unread)
Bile Duct Cancer
(664 unread)
Brain and CNS
(597 unread)
Carcinoid
(153 unread)
Endocrine/Neuroendocrine
(652 unread)
Gall Bladder Cancer
(338 unread)
Hemangioendothelioma
(117 unread)
Hepatoblastoma
(151 unread)
Pancreas
(60 unread)
Phyllodes
(26 unread)
PMP and Mucinous Tumors
(39 unread)
Rhabdomyosarcoma
(187 unread)
Sarcoma
(925 unread)
Google - Neuroendocrine Tumor (100 unread)
-
Creating Through Cancer: Finding the Strength to Keep Writing - Publishers Weekly
Posted: November 30th, 2021, 7:36pm GMT
Creating Through Cancer: Finding the Strength to Keep Writing Publishers Weekly -
RayzeBio-Partnered Startup Focused on Bringing Radiopharmaceuticals to China - BioSpace
Posted: November 30th, 2021, 2:30pm GMT
-
UI Health Care designated first Pheo Para Cancer Center of Excellence in Iowa and surrounding states | Holden - University of Iowa Health Care
Posted: November 30th, 2021, 12:26pm GMT
UI Health Care designated first Pheo Para Cancer Center of Excellence in Iowa and surrounding states | Holden University of Iowa Health Care -
Understanding and targeting prostate cancer cell heterogeneity and plasticity - DocWire News
Posted: November 30th, 2021, 12:03pm GMT
-
NET treatment in Germany - TNT Magazine
Posted: November 29th, 2021, 8:11pm GMT
NET treatment in Germany TNT Magazine -
Lantheus Announces PYLARIFY AI™ is Now Available | Your Money | kulr8.com - KULR-TV
Posted: November 29th, 2021, 11:30am GMT
-
10 rare cancers: Symptoms, treatment, and more - Medical News Today
Posted: November 29th, 2021, 6:00am GMT
10 rare cancers: Symptoms, treatment, and more Medical News Today -
Tidutamab Induces Best Overall Response of Stable Disease in Advanced Neuroendocrine Tumors - www.oncnursingnews.com/
Posted: November 27th, 2021, 2:07pm GMT
Tidutamab Induces Best Overall Response of Stable Disease in Advanced Neuroendocrine Tumors www.oncnursingnews.com/ -
Neuroendocrine Tumor Drug Market to Witness Growth Acceleration During 2021 to 2026 - Northwest Diamond Notes
Posted: November 27th, 2021, 10:44am GMT
Neuroendocrine Tumor Drug Market to Witness Growth Acceleration During 2021 to 2026 Northwest Diamond Notes -
RSNA 2021 planner: AI educational sessions - AI in Healthcare
Posted: November 26th, 2021, 2:41pm GMT
RSNA 2021 planner: AI educational sessions AI in Healthcare -
Half of VHL-Associated Kidney Tumors Respond to HIF2A Inhibitor - MedPage Today
Posted: November 26th, 2021, 11:01am GMT
-
Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force) - DocWire News
Posted: November 26th, 2021, 4:00am GMT
-
Helen Rose Janson, 64 - RiverheadLOCAL
Posted: November 25th, 2021, 10:05am GMT
Helen Rose Janson, 64 RiverheadLOCAL -
Little Things Can Cause Big Issues in Patient Care - Pharmacy Practice News
Posted: November 25th, 2021, 6:00am GMT
Little Things Can Cause Big Issues in Patient Care Pharmacy Practice News -
New, improved organoids shed light on untreatable form of prostate cancer - News-Medical.net
Posted: November 25th, 2021, 2:01am GMT
-
New ASTRO President Calls Attention to In-Person Meetings, Remaining Challenges, and Ongoing Research in Radiation Oncology - OncLive
Posted: November 24th, 2021, 9:24pm GMT
-
Helen Rose Janson - The Suffolk Times - Suffolk Times
Posted: November 24th, 2021, 6:13pm GMT
Helen Rose Janson - The Suffolk Times Suffolk Times -
Helen Rose Janson - Riverhead News Review - Riverhead News Review
Posted: November 24th, 2021, 6:12pm GMT
Helen Rose Janson - Riverhead News Review Riverhead News Review -
Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study - Yahoo Finance
Posted: November 24th, 2021, 10:00am GMT
-
Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 1 Ifenprodil Small Cell Lung Cancer Study - GlobeNewswire
Posted: November 24th, 2021, 10:00am GMT
-
Complete and durable response of pulmonary large-cell neuroendocrine carcinoma to pembrolizumab - DocWire News
Posted: November 24th, 2021, 4:00am GMT
-
Quantitative assessment of the impact of COVID-19 pandemic on pancreatic surgery: an Italian multicenter analysis of 1423 cases from 10 tertiary referral centers - DocWire News
Posted: November 24th, 2021, 4:00am GMT
-
Quantitative assessment of the impact of COVID-19 pandemic on pancreatic surgery: an Italian multicenter analysis of 1423 cases from 10 tertiary referral centers - DocWire News
Posted: November 24th, 2021, 4:00am GMT
-
Study proves safety and effectiveness of novel radionuclide therapy for neuroendocrine neoplasms - News-Medical.net
Posted: November 24th, 2021, 1:47am GMT
-
LEMS Case Tied to Rare Subtype of Lung Cancer - Lambert-Eaton News
Posted: November 23rd, 2021, 3:39pm GMT
LEMS Case Tied to Rare Subtype of Lung Cancer Lambert-Eaton News -
Behind the FDA Approval: Belzutifan for VHL-Associated Renal Cell Carcinoma - Targeted Oncology
Posted: November 23rd, 2021, 2:00pm GMT
-
Shifting to Patient-Centered Care Allows Thoughtful Opioid Use - Specialty Pharmacy Continuum
Posted: November 23rd, 2021, 1:50pm GMT
Shifting to Patient-Centered Care Allows Thoughtful Opioid Use Specialty Pharmacy Continuum -
Novel radionuclide therapy proven safe and effective to treat neuroendocrine neoplasms - Medical Xpress
Posted: November 23rd, 2021, 1:43pm GMT
-
A Broken Rib Leads to Early Detection of Lung Cancer in Husband and Wife - UConn Today - UConn Today
Posted: November 23rd, 2021, 1:12pm GMT
-
How Von Hippel-Lindau Disease Is Treated - Verywell Health
Posted: November 22nd, 2021, 9:10pm GMT
How Von Hippel-Lindau Disease Is Treated Verywell Health -
Von Hippel-Lindau Disease: Symptoms and Causes - Verywell Health
Posted: November 22nd, 2021, 8:06pm GMT
Von Hippel-Lindau Disease: Symptoms and Causes Verywell Health -
Appendix Cancer: Stages, Symptoms, Treatment & More - Healthline
Posted: November 22nd, 2021, 2:53pm GMT
-
Multidisciplinary care key in updated pheochromocytoma, paraganglioma guideline - Healio
Posted: November 22nd, 2021, 12:43pm GMT
-
Lantheus Announces CMS Grants Transitional Pass-Through Payment for PYLARIFY® (piflufolastat F ... - KULR-TV
Posted: November 22nd, 2021, 11:30am GMT
-
Telotristat Ethyl Linked to Patient Satisfaction in Carcinoid Syndrome - www.oncnursingnews.com/
Posted: November 20th, 2021, 6:00am GMT
Telotristat Ethyl Linked to Patient Satisfaction in Carcinoid Syndrome www.oncnursingnews.com/ -
Influx of Therapies in NETs Prompts Questions Over Combinations and Sequencing - OncLive
Posted: November 19th, 2021, 1:11pm GMT
-
Gastroenteropancreatic Neuroendocrine Tumor Therapeutics Market Potential Growth, Share, Demand And Analysis O - openPR
Posted: November 19th, 2021, 12:59pm GMT
-
Global Brain Cancer Therapeutics Market to Surpass US$ - GlobeNewswire
Posted: November 19th, 2021, 12:00pm GMT
Global Brain Cancer Therapeutics Market to Surpass US$ GlobeNewswire -
Scots dad given terminal cancer diagnosis told tumour is stable after Covid fight for life - Scottish Daily Record
Posted: November 19th, 2021, 7:57am GMT
-
Dr. Kunz on the Importance of Tailoring Treatments to Patients With NETs - OncLive
Posted: November 18th, 2021, 5:53pm GMT
-
Kimberly Sue Bromm | Obituaries | pdclarion.com - pdclarion.com
Posted: November 18th, 2021, 4:56pm GMT
Kimberly Sue Bromm | Obituaries | pdclarion.com pdclarion.com -
Assay for patient-specific monitoring and treatment for ovarian cancer - Medical Xpress
Posted: November 18th, 2021, 1:34pm GMT
-
Small-cell neuroendocrine tumor of the bladder: A rare disease in a low-risk woman - DocWire News
Posted: November 18th, 2021, 12:02pm GMT
-
Diagnosing pancreatic cancer: what are the symptoms? - Baylor College of Medicine Blog Network - Baylor College of Medicine News
Posted: November 18th, 2021, 12:00pm GMT
Diagnosing pancreatic cancer: what are the symptoms? - Baylor College of Medicine Blog Network Baylor College of Medicine News -
HER2 amplification in advanced NSCLC patients | OTT - Dove Medical Press
Posted: November 18th, 2021, 4:23am GMT
HER2 amplification in advanced NSCLC patients | OTT Dove Medical Press -
Subsequent-line Treatment in Advanced RCC Leaves Room for Personalization - OncLive
Posted: November 17th, 2021, 1:26pm GMT
-
Lantheus Holdings Announces Presentations Featuring PYLARIFY® (Piflufolastat F 18), its ... - KULR-TV
Posted: November 17th, 2021, 11:30am GMT
-
Neuroendocrine Tumor Treatment Market: How the Companies Have Adopted the Changes and Impacting the Industry, Players – Bristol-Myers, Squibb Eli Lilly . – Energy Siren - Energy Siren
Posted: November 17th, 2021, 8:21am GMT
-
Exclusive Research Report On Neuroendocrine Tumor Treatment Market 2021. Major Players – Exelixis, Inc., Advanced Accelerator Applications, Dauntless Pharmaceuticals, Inc., Hutchinson Medipharma Limited, Ispen, etc. – Energy Siren - Energy Siren
Posted: November 17th, 2021, 7:45am GMT
-
University of Missouri Research Reactor still breaking new ground in 5th decade of operation - Medical Xpress
Posted: November 17th, 2021, 6:48am GMT
-
Sunitinib Malate Market 2021 Share, Size, Growth, Regional Industry Segmentation, Key Companies, CAGR Status by 2027 | Pfizer, J&K Scientific, Topcarepharm, Njfirstpharm, Targetmol…. – Energy Siren - Energy Siren
Posted: November 17th, 2021, 4:04am GMT
-
Somatostatin Analogs Market 2021 Analysis by Size, Share, Growth, Trends up to 2027 | Novartis, Ipsen Biopharmaceutical, Peptron, Chiasma…. – Energy Siren - Energy Siren
Posted: November 17th, 2021, 3:47am GMT
-
[FREE PDF] Turkey Solar Photovoltaic Market Report- Top Companies, Trends and Growth Factors Details for Business Development by 2025 – Energy Siren - Energy Siren
Posted: November 17th, 2021, 3:40am GMT
-
Voice Recognition Software Market to Witness Huge Growth by 2028 | Dragon Professional Individual v15, LilySpeech, Braina Pro – Energy Siren - Energy Siren
Posted: November 17th, 2021, 3:40am GMT
-
University of Missouri Research Reactor still - EurekAlert
Posted: November 16th, 2021, 9:07pm GMT
-
Doctors seeing a rise in pancreatic cancer cases, especially in younger women - WTNH.com
Posted: November 16th, 2021, 9:03pm GMT
-
Doctors seeing a rise in pancreatic cancer cases, especially in younger women - WTNH.com
Posted: November 16th, 2021, 9:03pm GMT
-
The Mechanism of PSMA PET for Prostate Cancer - Stefano Fanti and Ken Herrmann - UroToday
Posted: November 16th, 2021, 8:52pm GMT
-
Biomarkers for the efficacy of PD-1-PD-L blockade in cancer | OTT - Dove Medical Press
Posted: November 16th, 2021, 3:57pm GMT
Biomarkers for the efficacy of PD-1-PD-L blockade in cancer | OTT Dove Medical Press -
Prostate Cancer Organoids Open Path to Precision Oncology - Georgia Tech College of Engineering
Posted: November 16th, 2021, 12:58pm GMT
Prostate Cancer Organoids Open Path to Precision Oncology Georgia Tech College of Engineering -
Peptide Receptor Radionuclide Therapy (PRRT) Market Witness Stunning Growth By 2028 | Novartis, ITM Solucin, National Institutes of Health – Energy Siren - Energy Siren
Posted: November 16th, 2021, 9:51am GMT
-
Causes and Risk Factors of Carcinoid Tumors - Verywell Health
Posted: November 15th, 2021, 6:19pm GMT
Causes and Risk Factors of Carcinoid Tumors Verywell Health -
Low Power Wide Area Network (LPWAN) Market Size by Top Companies, Trends by Types and Application, Forecast to 2028 | Semtech Corporation, Weightless Sig, AT&T Inc, Huawei Technologies – Energy Siren - Energy Siren
Posted: November 15th, 2021, 4:24pm GMT
-
Pembrolizumab/Chemo Not Effective in Extrapulmonary Poorly Differentiated Neuroendocrine Carcinomas - OncLive
Posted: November 15th, 2021, 1:05pm GMT
-
What Sunitinib Malate Market Growth is Meant for Adjacent Industries with Insights on Players – Fedelty Health Care Private Limited – Energy Siren - Energy Siren
Posted: November 15th, 2021, 12:15pm GMT
-
Telotristat Ethyl Improves Symptoms and Patient Satisfaction in Carcinoid Syndrome - OncLive
Posted: November 15th, 2021, 12:01pm GMT
-
Qualitative Analysis of Somatostatin Analogs Market 2021-2026 Strategical Assessment of Novartis, Peptron, Chiasma, Ipsen Biopharmaceutical,,, and more | Affluence – Energy Siren - Energy Siren
Posted: November 15th, 2021, 7:26am GMT
-
Pharmaceutical Waste Disposal & Management Market Size by Top Companies, Trends by Types and Application, Forecast to 2028 | Sharps Compliance, US Ecology, Stericycle, Waste Management – Energy Siren - Energy Siren
Posted: November 15th, 2021, 11:05pm GMT
-
Gastroenteropancreatic Neuroendocrine Tumor Therapeutics Market 2021 Detailed Analysis of top Ventures with Regional Outlook | Key Companies: Novartis, Tarveda Therapeutics, Teva Pharmaceuticals, P… – Energy Siren - Energy Siren
Posted: November 15th, 2021, 11:05pm GMT
-
Neuroendocrine Tumor Treatment Market Industry Outlook, Comprehensive Insights, Growth and Forecast 2031 – Energy Siren - Energy Siren
Posted: November 14th, 2021, 1:28pm GMT
-
R134A Refrigerant Market Research Report and Forecast to 2028 – Mexichem Fluor, Chemours, Honeywell – Energy Siren - Energy Siren
Posted: November 14th, 2021, 1:28pm GMT
-
Global Cancer mTOR Inhibitors Market Research Report Contains - Key Players, Industry Overview, Supply Chain, Analysis and Forecast to 2021-2026 - Northwest Diamond Notes
Posted: November 14th, 2021, 11:42am GMT
-
Global Neuroendocrine Tumor Drug Market 2021: SWOT Analysis of Key Driving Factors for Growing CAGR Value | Top Brands: Eisai, Exelixis, Inc., Foresee Pharmaceuticals, LLC, Hutchison MediPharma Lim… – LSMedia - LSMedia
Posted: November 14th, 2021, 9:37am GMT
-
Elimination of Perioperative Octreotide Does Not Increase Rate or Duration of Carcinoid Crisis in NETs - OncLive
Posted: November 14th, 2021, 9:08am GMT
-
Emirates Oncology Society and Ipsen break Guinness World Rec... - MENAFN.COM
Posted: November 13th, 2021, 4:01pm GMT
-
Somatostatin Receptor Type 4 Market Overview 2021: Growth Report explores industry trends, Business Statistics, Regional Analysis | Centrexion Therapeutics, CRINETICS PHARMACEUTICALS and Strongbridge Biopharma – Energy Siren - Energy Siren
Posted: November 13th, 2021, 11:27am GMT
-
Automotive Fan Blades Market Growth Statistics and Industry Trends 2021 | Size, Share, Business Strategies, Emerging Technology, Product Portfolio for Forecast 2026, Data from The Largest Countries, Producer Analysis and Demand Status – Energy Siren -
Posted: November 13th, 2021, 11:06am GMT
-
Surufatinib/Toripalimab Combo Elicits Encouraging Efficacy in Advanced Neuroendocrine Carcinoma - OncLive
Posted: November 13th, 2021, 9:12am GMT
-
Commentary: Rare form of slow-moving cancer can hide behind common symptoms - Press Herald
Posted: November 13th, 2021, 7:00am GMT
-
Adult Milk Powder Market 2021-2026 Size and Share, Recent Enhancements and Regional Analysis | Key Companies: Abbott, Yashily, Murray Goulburn, Nestle, Fasska, Anlene, Anchor, Yili, Régilait, Vreu... - Energy Siren
Posted: November 13th, 2021, 12:08am GMT
-
Medical Apparel Market 2021 Latest Insights, Growth Rate, Future Trends and Forecast | Oprating Vendors: Superior Uniform Group, Dohia, FIGS, Landau Scrubs, Barco Uniform, Strategic Partners, Graha... - Energy Siren
Posted: November 13th, 2021, 12:08am GMT
-
Veterinary Doppler Market 2021 Analysis by Size, Share, Growth, Trends up to 2027 | BMV Technology, CHISON Medical Imaging, DRE Veterinary, Eickemeyer Veterinary Equipment - Energy Siren
Posted: November 13th, 2021, 12:08am GMT
-
Imaging/X-Ray Service | VA Portland Health Care - Veterans Affairs
Posted: November 12th, 2021, 9:01pm GMT
Imaging/X-Ray Service | VA Portland Health Care Veterans Affairs -
Pamela Kunz, MD, of Yale Named 'Woman Oncologist of the Year' - Medscape
Posted: November 12th, 2021, 3:46pm GMT
-
Hormone-producing Intestinal Tumor Causes Rare Cushing's Case - Cushing's Disease News
Posted: November 12th, 2021, 3:39pm GMT
Hormone-producing Intestinal Tumor Causes Rare Cushing's Case Cushing's Disease News -
Business Overview of Media Monitoring Tools Industry Size, Emerging Trends and Forecast to 2021-2026 - Energy Siren
Posted: November 12th, 2021, 2:40pm GMT
-
Global Neuroendocrine Tumor Drug Market 2021: SWOT Analysis of Key Driving Factors for Growing CAGR Value | Top Brands: Eisai, Exelixis, Inc., Foresee Pharmaceuticals, LLC, Hutchison MediPharma Lim... - Energy Siren
Posted: November 12th, 2021, 2:40pm GMT
-
Tazemetostat in Combination With Abiraterone + Prednisone or Enzalutamide in mCRPC – Wassim Abida - UroToday
Posted: November 12th, 2021, 11:37am GMT
-
POINT Biopharma Reports Third Quarter 2021 Financial Results and Provides Business Update - Yahoo Finance
Posted: November 12th, 2021, 11:30am GMT
-
POINT Biopharma Reports Third Quarter 2021 Financial Results and Provides Business Update - GlobeNewswire
Posted: November 12th, 2021, 11:30am GMT
-
Vincerx Pharma Reports Third Quarter 2021 Financial Results and Provides a Corporate Update - StreetInsider.com
Posted: November 12th, 2021, 11:07am GMT
-
Vincerx Pharma Reports Third Quarter 2021 Financial Results and Provides a Corporate Update - Yahoo Finance
Posted: November 12th, 2021, 11:00am GMT
-
Elevation Oncology Reports Third Quarter 2021 Financial Results | National News | kpvi.com - KPVI News 6
Posted: November 12th, 2021, 10:30am GMT
-
Elevation Oncology Reports Third Quarter 2021 Financial Results - PRNewswire
Posted: November 12th, 2021, 10:30am GMT
-
Cancer conference addresses living well during a pandemic - Quoddy Tides
Posted: November 12th, 2021, 6:00am GMT
-
Dental Matrix Systems Market 2021 Analysis by Size, Share, Growth, Trends up to 2027 | Dentsply Sirona, KerrDental, Polydentia, Garrison Dental Solutions LLC - Energy Siren
Posted: November 12th, 2021, 1:50am GMT
-
Other news to note for Nov. 11, 2021 | 2021-11-11 - BioWorld Online
Posted: November 11th, 2021, 8:20pm GMT
Other news to note for Nov. 11, 2021 | 2021-11-11 BioWorld Online -
Fayetteville principal shares experience battling neuroendocrine cancer as tribute to awareness day - The Fayetteville Observer
Posted: November 11th, 2021, 3:50pm GMT
Fayetteville principal shares experience battling neuroendocrine cancer as tribute to awareness day The Fayetteville Observer -
Camurus announces dosing initiated in Phase 3 study of CAM2029 in patients with neuroendocrine tumors - marketscreener.com
Posted: November 11th, 2021, 11:02am GMT
-
Emirates Oncology Society And Ipsen Break Guinness World Recor... - PressReleaseNetwork.com
Posted: November 11th, 2021, 6:50am GMT
Emirates Oncology Society And Ipsen Break Guinness World Recor... PressReleaseNetwork.com